Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jul 27, 2026
Entia Biosciences Market Cap
Entia Biosciences has a market cap or net worth of $6.81 thousand as of July 31, 2026. Its market cap has increased by 100.00% in one year.
Market Cap
6.81K
Enterprise Value
n/a
Revenue
265.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since January 18, 2008, Entia Biosciences's market cap has decreased from 3.26M to 6.81K, a decrease of -99.79%. That is a compound annual growth rate of -28.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 6.81K | -33.33% |
| Dec 31, 2025 | 10.22K | 50.00% |
| Dec 13, 2024 | 6.81K | - |
| Dec 27, 2022 | 6.81K | -86.67% |
| Dec 31, 2021 | 51.09K | -88.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioasis Technologies | 7.94K |
| Statera Biopharma | 7.26K |
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.17K |
| Theralink Technologies | 6.15K |
| MetaStat | 5.88K |
| Hard to Treat Diseases | 5.82K |
| Evelo Biosciences | 5.70K |